I now have excellent, detailed content from multiple authoritative textbooks. Let me compile the comprehensive answer.
Newer Modes of Ventilation
Modern ventilators have moved well beyond simple volume-control and pressure-control modes. The newer modes aim to reduce ventilator-induced lung injury (VILI), improve patient-ventilator synchrony, and adapt to changing patient mechanics in real time.
1. Pressure-Regulated Volume Control (PRVC)
PRVC is a hybrid mode that combines the benefits of pressure-controlled and volume-controlled ventilation. The ventilator delivers a pressure-targeted, time-cycled breath, but it automatically adjusts the inspiratory pressure breath-by-breath to achieve the clinician-set tidal volume (VT).
- After each breath, the ventilator checks whether the delivered V
T was adequate; if too low or too high, it adjusts the next breath's pressure accordingly.
- The result is a decelerating, variable flow pattern that is generally more comfortable for the patient than a fixed-flow volume-controlled breath.
- If respiratory mechanics improve (compliance rises), the ventilator reduces the applied pressure; if mechanics worsen, pressure increases to maintain the target volume.
- Volume Support (VS) is a closely related mode but applies to spontaneous (pressure-support style) breaths where the pressure target is auto-adjusted to achieve a set V
T.
Murray & Nadel's Textbook of Respiratory Medicine, p. 3175; Washington Manual of Medical Therapeutics, p. 288
2. Airway Pressure Release Ventilation (APRV)
APRV is an extreme form of inverse-ratio ventilation designed for patients with severely reduced compliance (classically ARDS).
Settings:
| Parameter | Role |
|---|
Phigh | High CPAP level - recruits alveoli and maintains oxygenation |
Thigh | Time at Phigh (prolonged, typically 4-6 sec) |
Plow | Release pressure (often 0 cm H2O) |
Tlow (release time) | Very short (<0.5-0.8 sec) - allows CO2 clearance without derecruitment |
Key features:
- Spontaneous breathing is permitted throughout the entire cycle (at any phase), which may enhance alveolar recruitment and improve cardiac filling compared to controlled modes.
- The short T
low prevents complete lung derecruitment on release.
- Patients may be permitted to become hypercapnic to pH 7.20 ("permissive hypercapnia").
- A meta-analysis of nearly 19 years of data in acute hypoxemic respiratory failure suggested a mortality benefit compared to conventional modes (Sabiston); however, most randomized studies comparing APRV to true lung-protective strategies have not shown consistent differences in outcomes.
- A single-center RCT in ARDS (n=138) found more ventilator-free days (19 vs. 2, P<0.001) and shorter ICU stay with APRV vs. volume assist-control, though methodological limitations exist.
Murray & Nadel's, p. 3175; Fishman's Pulmonary Diseases, p. 2505; Sabiston Textbook of Surgery; Washington Manual, p. 288
3. High-Frequency Oscillatory Ventilation (HFOV)
HFOV delivers very small tidal volumes (often less than anatomic dead space, <100 mL) at very high frequencies (120-900 breaths/min in adults).
Mechanism of gas exchange (not simple bulk flow):
- Taylor dispersion
- Coaxial flow (fresh gas flows centrally while CO
2 exits peripherally)
- Augmented molecular diffusion
- Asymmetric velocity profiles
Physiologic rationale:
- The mean airway pressure is set at a level that maintains oxygenation (alveolar recruitment).
- The small oscillatory pressure swings on top of the mean pressure handle CO
2 clearance.
- Theoretically the "ultimate" low-tidal-volume ventilator - small alveolar pressure swings minimize cyclic overdistention and derecruitment.
Clinical evidence:
- OSCAR trial: No mortality benefit vs. usual care.
- OSCILLATE trial: Stopped early - HFOV arm showed higher in-hospital mortality vs. low V
T/high-PEEP control group.
- Currently used only as a salvage mode in refractory hypoxemia or as a bridge to ECMO; even in this role, controlled trial evidence is lacking.
- May have a role in the pediatric population.
Fishman's Pulmonary Diseases, p. 2505; Murray & Nadel's, p. 3175; Washington Manual, p. 288
4. Adaptive Support Ventilation (ASV)
ASV is an assist-control, pressure-targeted, time-cycled mode that uses real-time respiratory mechanics to automatically set the VT-frequency pattern.
- The clinician sets only the desired minute ventilation and the patient's height (used to estimate anatomic dead space).
- The ventilator continuously measures resistance and compliance, calculates the expiratory time constant (R x C), and adjusts the frequency-V
T pattern to minimize the work of ventilation (integral of pressure over volume).
- The breathing pattern is also modulated to avoid air trapping (using the expiratory time constant).
- When the patient triggers breaths, ASV behaves like volume-support mode.
- As respiratory mechanics change (e.g., during weaning), the pattern is automatically adjusted.
Murray & Nadel's Textbook of Respiratory Medicine, p. 3175-3176
5. Proportional Assist Ventilation (PAV / PAV+)
PAV delivers inspiratory pressure in direct proportion to patient effort - as the patient works harder, the ventilator delivers more pressure; when effort decreases, support decreases.
PAV+ (load-adjustable gain factors):
- Uses transient end-inspiratory occlusions to measure respiratory system elastance (1/compliance) and resistance.
- Estimates the pressure required to inflate the respiratory system using the equation of motion:
Pventilator = Gain × (Elastance × Volume + Resistance × Flow)
- The ventilator delivers a fixed proportion (the "gain," set by clinician, e.g., 50-80%) of this total inflation pressure.
- Result: Greater patient effort → greater delivered pressure → respiratory muscles are unloaded in proportion.
Advantages over conventional modes:
- In pressure-targeted modes, delivered ventilation is essentially independent of effort.
- In volume-targeted modes, delivered ventilation actually decreases when effort increases (since increased flow from patient reduces ventilator flow delivery).
- PAV+ corrects this mismatch, making it more physiologic.
Murray & Nadel's Textbook of Respiratory Medicine, p. 3176
6. Neurally Adjusted Ventilatory Assist (NAVA)
NAVA is the most physiologic of the newer modes - it uses the diaphragm's own electrical signal to control ventilator output.
Mechanism:
- A specially designed nasogastric tube with EMG electrodes is placed esophageally to detect the electrical activity of the diaphragm (Edi) via the diaphragmatic crura.
- The ventilator delivers pressure in direct proportion to Edi magnitude: P
delivered = NAVA level × Edi.
Advantages:
- Triggering occurs at neural onset (before airway pressure or flow signals change) - eliminates trigger delay.
- Cycling-off is also neural - ends when Edi falls, eliminating over-assistance or under-assistance.
- Improves patient-ventilator synchrony, especially in patients with intrinsic PEEP (auto-PEEP), high respiratory drive, or weak efforts.
- Reduces asynchrony events (double triggering, missed triggers, premature cycling).
- Applicable even in non-invasive ventilation (NIV-NAVA).
- Used in neonates, pediatric patients, and adults.
Murray & Nadel's Textbook of Respiratory Medicine, p. 3176; Miller's Anesthesia, 10e; Fishman's Pulmonary Diseases
7. Inverse Ratio Ventilation (IRV)
IRV is a pressure-controlled mode where inspiratory time exceeds expiratory time (I:E ratio >1:1, e.g., 2:1 or 3:1).
- Raises mean airway pressure and recruits slowly-filling alveoli, improving oxygenation in ARDS.
- The short expiratory time can create auto-PEEP (intrinsic PEEP), which may be the actual mechanism of improved oxygenation.
- Hazard: In obstructive lung disease, auto-PEEP can cause severe hyperinflation and hemodynamic compromise.
- Patients are permitted hypercapnia to pH 7.20.
- APRV is considered an extreme form of IRV.
Washington Manual of Medical Therapeutics, p. 288
8. Bilevel Positive Airway Pressure (BiPAP / BIPAP as invasive mode)
BiPAP in the ICU context (distinct from non-invasive BiPAP) delivers two levels of CPAP and allows spontaneous breathing at both pressure levels.
- Similar to APRV but with a longer T
low (more balanced I:E ratio).
- Minimizes pressures seen by alveoli.
- Most commonly used in patients with severely reduced lung compliance (ARDS).
Summary Table
| Mode | Key Principle | Primary Use | Notable Evidence |
|---|
| PRVC | Pressure-limited, volume-guaranteed | General ICU | Widely used |
| APRV | Prolonged Phigh, brief release | ARDS, refractory hypoxemia | Mixed RCT data; possible mortality benefit |
| HFOV | Sub-dead-space VT at 120-900/min | ARDS salvage, bridge to ECMO | OSCAR/OSCILLATE: no benefit, possible harm |
| ASV | Auto-adjusts VT/rate to mechanics | Weaning, general support | Reduces over/under-ventilation |
| PAV+ | Pressure proportional to effort (mechanics-based) | Synchrony improvement | Reduces patient effort variability |
| NAVA | Pressure proportional to diaphragm EMG | Synchrony, difficult-to-wean | Best synchrony; reduces asynchrony events |
| IRV | I>E ratio improves oxygenation | ARDS | Used as precursor/alternative to APRV |
Clinical note: Advanced modes (APRV, HFOV, NAVA, PAV+, ASV) should generally be used only after discussion with experienced practitioners or respiratory therapy specialists. For ARDS specifically, low-tidal-volume ARDSNet strategy (6 mL/kg IBW, Pplat ≤30 cmH2O) remains the standard; newer modes are used when conventional approaches fail or for specific synchrony indications.
Sources: Murray & Nadel's Textbook of Respiratory Medicine; Fishman's Pulmonary Diseases and Disorders; Sabiston Textbook of Surgery; Washington Manual of Medical Therapeutics; Miller's Anesthesia, 10e